Thanks for this. I would like to hear NP address it to though. They made a big deal about it initially and suggested it would be published very quickly, but then went quiet on the topic and have since mentioned a couple of new papers being written. I think the company owes us an update on BP's paper, even if it's just a paltry "BP has been answering questions and hopefully published soon."

Like someone else said, publication before the trial data and FDA's decision would be ideal.